However, the medication itself can cause temporary increases in heart rate or blood pressure during the first few weeks as your body adapts to new hormone signaling
adults eligible for semaglutide highlights its potential transformative impact on population health, said Shi
Similarly, each cell is also exposed to oxidative damage caused by outside chemicals and toxins
Metabolic indicators that may correlate with reduced GLP-1 activity include: Persistent hyperglycemia despite dietary modifications, particularly elevated postprandial (after-meal) blood glucose levels Difficulty achieving satiety after meals, leading to continued hunger and frequent snacking Progressive weight gain that is resistant to conventional dietary interventions Diagnosis of prediabetes or type 2 diabetes , conditions associated with impaired incretin response Metabolic syndrome features , including central obesity, hypertension, and dyslipidemia It is important to emphasize that these signs are not diagnostic of GLP-1 imbalance specifically, as they can result from numerous metabolic, endocrine, or lifestyle factors
Simon Cork, Senior Lecturer in Physiology, Anglia Ruskin University This article is republished from The Conversation under a Creative Commons license